Results 81 to 90 of about 13,947 (241)

Preliminary Validation of the Early Sacroiliitis Screening Tool (ESHST) for Identifying Hidradenitis Suppurativa Patients at High Risk of Spondyloarthritis

open access: yesInternational Journal of Dermatology, EarlyView.
Development and preliminary validation of the Early Sacroiliitis Screening Tool (ESHST), a dermatology‐oriented screening questionnaire for identifying hidradenitis suppurativa patients at increased risk of spondyloarthritis. ABSTRACT Background Hidradenitis suppurativa (HS) is increasingly recognized as a systemic inflammatory disease associated with ...
Umut Bakay   +3 more
wiley   +1 more source

PD-L1-Inhibitor-Associated Hidradenitis Suppurativa. [PDF]

open access: yesJ Cutan Pathol
Journal of Cutaneous Pathology, Volume 53, Issue 9, Page 759-761, September 2026.
Jin A, Steele KT, Chu EY.
europepmc   +2 more sources

Therapeutic Inertia in Hidradenitis Suppurativa: Could Defensive Medicine Play a Role?

open access: yes
JEADV Clinical Practice, EarlyView.
Anju George, Alejandro Molina‐Leyva
wiley   +1 more source

Smartphone Applications in Dermatology With Special Focus on AI: A European‐Continent‐Based Review

open access: yesInternational Journal of Dermatology, EarlyView.
Our analysis of 420 dermatology mobile applications across 44 European countries revealed limited adoption of artificial intelligence and sparse scientific validation. ABSTRACT Smartphone applications for dermatology are widely available across Europe, yet evidence on their characteristics, validation, and regulatory compliance remains limited.
Tobias Sangers   +23 more
wiley   +1 more source

A Real‐Life, Multicenter, Retrospective Study on Epidemiological and Clinical Features of Patients With Hidradenitis Suppurativa and Concomitant Down Syndrome

open access: yesInternational Journal of Dermatology, EarlyView.
Summary of the clinical characteristics and 2‐year follow‐up of patients with HS and concomitant DS in a multicentre Italian cohort, highlighting earlier HS onset, clinical features, and improved disease severity, quality of life, and pain over follow‐up, supporting early screening and multidisciplinary care of this special population.
Chiara Moltrasio   +34 more
wiley   +1 more source

Hidradenitis Suppurativa Online Documents Readability: An Analysis Including 23 European Languages [PDF]

open access: yes
Tomasz Skrzypczak,1 Anna Skrzypczak,2 Jacek C Szepietowski1 1Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland; 2Department of Periodontology, Wroclaw Medical University, Wroclaw, PolandCorrespondence ...
Skrzypczak T   +2 more
core  

Dissecting Cellulitis and Hidradenitis Suppurativa: Two Diseases or One Follicular‐Occlusion Spectrum?

open access: yesInternational Journal of Dermatology, EarlyView.
Graphical abstract summarizing evidence that dissecting cellulitis of the scalp (DC) and hidradenitis suppurativa (HS) may represent site‐modified expressions of a shared follicular‐occlusion pathway, highlighting convergent clinical, histopathologic, and therapeutic features, the diagnostic‐context paradox, and the need for paired molecular studies ...
Giuseppe Gallo   +6 more
wiley   +1 more source

Hidradenitis suppurativa: an update [PDF]

open access: yesClinical Medicine, 2016
Hidradenitis suppurativa (HS) is a chronic, painful skin disease characterised by recurrent inflammatory lesions in flexural locations such as the axillae, groins and perineum. The papules, nodules and abscesses may discharge blood-stained pus which, combined with pain, results in marked quality-of-life reduction.
openaire   +2 more sources

Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment

open access: yes, 2017
Maddalena Napolitano,1 Matteo Megna,2 Elena A Timoshchuk,3 Cataldo Patruno,2 Nicola Balato,2 Gabriella Fabbrocini,2 Giuseppe Monfrecola2 1Dipartimento di Medicina e Scienze della Salute “Vincenzo Tiberio”, Università degli Studi del ...
Monfrecola G   +6 more
core  

Delphi consensus: First‐line use of biologics and small molecules in hidradenitis suppurativa

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
This Delphi Consensus study identified upgrade criteria for the use of biologics and small molecules as first‐line therapy in hidradenitis suppurativa (HS). European HS experts evaluated 16 clinical scenarios, voting on eligibility for therapy escalation.
Georgios Nikolakis   +54 more
wiley   +1 more source

Home - About - Disclaimer - Privacy